Yersinia Pestis Epidemiology and Pathogenesis

Summary

Yersinia pestis, the bacterium responsible for plague, has shaped human history through recurrent pandemics and focal outbreaks. Emerging from an enteric ancestor less than 6,000 years ago, it acquired unique virulence determinants and a capacity for flea-borne transmission. In its sylvatic cycle, wild rodents serve as reservoirs while flea vectors transmit the pathogen to humans, giving rise to distinct clinical syndromes. Bubonic plague, the most common form, is marked by fever and swollen lymph nodes (buboes); pneumonic plague involves rapid lung infection with high mortality in the absence of prompt treatment; septicemic plague arises when bacteria invade the bloodstream. Global epidemiology today reflects the persistence of foci in regions of Africa, Asia and the Americas, modulated by rodent and flea ecology, climatic factors and human activity. At the molecular level, key virulence factors—Yersinia outer-membrane proteins (Yops), the Pla protease and the F1 capsular antigen—subvert innate immunity, facilitating colonisation of lymphatic tissue and dissemination. Advances in genomic sequencing have traced the pathogen’s prehistoric origins, historic pandemic dynamics and modern resurgence, informing vaccine development, diagnostic assays and public-health interventions.

Research from Nature Portfolio

Genomic analyses of Late Neolithic and Bronze Age remains have pushed back the timeline of plague presence in Europe, revealing Y. pestis strains in Britain circa 4,000 years ago that belong to a sublineage lacking the yapC virulence factor yet demonstrating wide dissemination. Complementary reconstructions of ca 3,800-year-old genomes from Eurasia indicate that genetic adaptations enabling efficient flea-mediated transmission, and thus bubonic disease, emerged at least a millennium earlier than previously thought. At the other end of the historical spectrum, high-resolution phylogeographic studies of second pandemic remains from medieval and post-Black Death sites have uncovered a diversification of lineages into multiple clades, the loss of genomic regions encoding virulence-related genes during late stages of the pandemic, and evidence for several independent disease reservoirs in and around Europe.

Yersinia Pestis Epidemiology and Pathogenesis publication trend

The graph below shows the total number of articles in yersinia pestis epidemiology and pathogenesis across all publications each year (not limited to Nature Index journals).

Technical terms

Zoonosis: An infectious disease that is transmissible from animals to humans.

Sylvatic cycle: The transmission cycle of a pathogen among wild animal hosts and vectors.

Yersinia outer-membrane proteins (Yops): A suite of effector proteins injected into host cells to disrupt immune responses.

Pla protease: A surface enzyme that promotes bacterial dissemination by degrading host proteins and activating plasminogen.

F1 capsular antigen: A surface polymer that prevents phagocytosis and serves as a key diagnostic and vaccine target.

References

  1. Yersinia pestis genomes reveal plague in Britain 4000 years ago. Nature Communications (2023).
  2. Analysis of 3800-year-old Yersinia pestis genomes suggests Bronze Age origin for bubonic plague. Nature Communications (2018).
  3. Phylogeography of the second plague pandemic revealed through analysis of historical Yersinia pestis genomes. Nature Communications (2019).
  4. Historical plague pandemics: perspectives from ancient DNA. Trends in Microbiology (2024).
  5. Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics. Genes & Immunity (2019).
  6. Understanding the Persistence of Plague Foci in Madagascar. PLOS Neglected Tropical Diseases (2013).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Index 2026 Regenerative medicine

Regenerative medicine has the potential to transform the treatment of chronic and life-threatening diseases. But major challenges remain, such as overcoming immune rejection and ensuring that new therapies are developed using more inclusive data sets. In this supplement, we explore the discoveries that are driving the field, the barriers that could limit its progress, and the teams and institutions that are making their mark.

Nature Index 2026 Regenerative medicine
Access for free
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.